Sign Out
THERODEL is indicated for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
Patients suffering from acute coronary syndrome: Non-ST segments elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction). In combination with acetylsalicylic acid (ASA).
ST segment elevation acute myocardial infarction. In combination with ASA in medically treated patients eligible for thrombolytic therapy.
Lanjutkan dengan Google